Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Robert Fowler and Yaseen Arabi.
Robert Fowler
Connection Strength
4.593
Yaseen Arabi
  1. Middle East Respiratory Syndrome. N Engl J Med. 2017 02 09; 376(6):584-594.
    View in: PubMed
    Score: 0.704
  2. Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians. BMC Anesthesiol. 2016 07 12; 16(1):36.
    View in: PubMed
    Score: 0.676
  3. The search for therapeutic options for Middle East Respiratory Syndrome (MERS). J Infect Public Health. 2016 May-Jun; 9(3):213-5.
    View in: PubMed
    Score: 0.663
  4. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
    View in: PubMed
    Score: 0.239
  5. How the COVID-19 pandemic will change the future of critical care. Intensive Care Med. 2021 Mar; 47(3):282-291.
    View in: PubMed
    Score: 0.233
  6. Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome. N Engl J Med. 2020 10 22; 383(17):1645-1656.
    View in: PubMed
    Score: 0.227
  7. Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome. Emerg Infect Dis. 2020 Jun; 26(6):1102-1112.
    View in: PubMed
    Score: 0.222
  8. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-ß1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Trials. 2020 Jan 03; 21(1):8.
    View in: PubMed
    Score: 0.215
  9. Macrolides in critically ill patients with Middle East Respiratory Syndrome. Int J Infect Dis. 2019 Apr; 81:184-190.
    View in: PubMed
    Score: 0.201
  10. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. Am J Respir Crit Care Med. 2018 03 15; 197(6):757-767.
    View in: PubMed
    Score: 0.190
  11. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-ß1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials. 2018 Jan 30; 19(1):81.
    View in: PubMed
    Score: 0.188
  12. Clinical spectrum of the Middle East respiratory syndrome coronavirus (MERS-CoV). J Infect Public Health. 2017 Mar - Apr; 10(2):191-194.
    View in: PubMed
    Score: 0.167
  13. Proceedings of the Middle East Respiratory Syndrome (MERS) Coronavirus research initiative workshop, September 9-10 2015 in Riyadh, KSA. J Infect Public Health. 2016 May-Jun; 9(3):205-7.
    View in: PubMed
    Score: 0.166
  14. Knowledge gaps in therapeutic and non-therapeutic research on the Middle East respiratory syndrome. Lancet Respir Med. 2016 Feb; 4(2):93-4.
    View in: PubMed
    Score: 0.164
  15. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):790-802.
    View in: PubMed
    Score: 0.060
  16. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):777-789.
    View in: PubMed
    Score: 0.060
  17. CMAJ. 2020 10 26; 192(43):E1323-E1333.
    View in: PubMed
    Score: 0.057
  18. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
    View in: PubMed
    Score: 0.057
  19. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020 05 19; 192(20):E536-E545.
    View in: PubMed
    Score: 0.055
  20. Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome. Influenza Other Respir Viruses. 2019 07; 13(4):382-390.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.